What Happened?
Emeryville, CA-based Novabay Pharmaceuticals Inc Appointed Thomas Paulson as Chief Financial Officer
About the Company
We are passionate about improving people`s daily lives by offering clinically proven solutions to common skin and eye care problems through digital channels, traditional domestic retailers, and international distributors. We are in the process of growing from a small single-product company into a profitable mid-sized multi-product company. Our leading product, Avenova®, is the only lid & lash solution that brings eyes back to life by setting the highest standards of purity and efficacy. We pioneered the use of hypochlorous acid in the eyecare space and intend on making Avenova a household name. Our motto is, “If you have eyes, you need Avenova!” We also recently acquired DERMAdoctor, LLC, a skincare company offering more than 30 dermatologist-developed skincare products. We plan to launch nine new products this year with the founder of DERMAdoctor doing well known media placements such as QVC.
About the Person
Thomas Paulson serves as Chief Financial Officer at NovaBay Pharmaceuticals. Prior to joining NovaBay, Mr. Paulson was a partner at Tatum LLC, an executive services and consulting firm in the United States.
Info Source
Company Announcement
Short Profile